Integrated Mesh-Fascial Closure for Incisional Hernia Repair
Official title: Prospective Comparative Evaluation of the Integrated Mesh-Fascial Closure (IMFC) Technique Versus Standard Closure of the Abdominal Wall: A Quasi-Experimental, Non-Randomized Study
Run by Hospital Zonal General De Agudos Mario V Larrain · NCT07843225 · Data updated 2026-11-12
This study tests whether incorporating a mesh into the fascial closure during incisional hernia repair helps reduce recurrences compared with standard closure, in adults who need mesh placement.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Hospital Zonal General De Agudos Mario V Larrain Academic / other |
| Locations | 1 site (Berisso, Buenos Aires) |
| Status | Recruiting |
| Started | September 28, 2026 |
| Main results expected | October 15, 2030 |
| Study ends | October 15, 2032 |
| Registry record updated | October 14, 2026 |
| Trial ID | NCT07843225 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults over 18 undergoing laparotomy with an indication for prophylactic mesh placement or undergoing repair for incisional/ventral hernia, including recurrent hernias and defects >4 cm.
✕Probably not a fit
Patients with active infection, contamination, non-viable tissue, loss of domain, or other exclusion criteria may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This prospective, non-randomized study compares two abdominal wall closure techniques in adults with incisional or ventral hernias and planned mesh use. One group uses the standard fascial closure with mesh fixed separately, while the other uses Integrated Mesh-Fascial Closure (IMFC), weaving a macroporous mesh into the fascial suture. Participants choose their group after informed consent and are followed for 18 to 24 months with clinical assessments and imaging to assess safety, feasibility, and recurrence. The study is conducted at a single center in Argentina and aims to standardize IMFC and compare outcomes to standard closure. Background data indicate incisional hernia is common and recurrence after mesh repair can be substantial, motivating this comparative evaluation.
Why it matters
Potential benefit: If successful, IMFC could lower hernia recurrence and improve long-term durability of repair.
How similar studies have gone: Prior description of the IMFC concept exists, with a non-randomized, prospective approach showing potential feasibility, but this study adds prospective comparison.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults older than 18 years of age * Patients with incisional (ventral) hernia * Patients with recurrent incisional hernia * Incisional hernias with a diameter greater than 4 cm * Patients undergoing laparotomy with an indication for prophylactic mesh placement Exclusion Criteria: * Active surgical site infection * Overt abdominal contamination * Tissue necrosis or inability to achieve primary fascial closure * Non-correctable loss of domain * Pregnant women or women of childbearing potential planning pregnancy or not using contraception during the follow-up period * Patients belonging to vulnerable populations, in accordance with Law 15.462 and applicable ethical guidelines * Active oncologic disease (patients with a cured oncologic history may be included)
Where it's running
-
Hospital Zonal General de Agudos "Dr. Mario V. Larrain
Berisso, Buenos Aires, Argentina Recruiting
Study contacts
- Principal investigator: Facundo B Mattano, MD — Hospital Zonal General de Agudos "Dr. Mario V. Larrain
- Study coordinator: Facundo B Mattano, MD
- Email: mattanofacundo@outlook.com
- Phone: +54 9 221 611-7976
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Comparing preoperative preparation methods for large incisional (ventral) hernias
This study will test whether botulinum toxin A injections, progressive preoperative pneumoperitoneum, their combination, or no special preparation best help adults with large or complex incisional/ventral hernias have safer, more successful surgery.
-
Minimally invasive laparoscopic and robotic repair for non-inguinal abdominal wall hernias
This registry will follow adults having laparoscopic or robotic repair for abdominal wall hernias (not inguinal) for five years to see how well the operations work and what complications occur.
-
Pre-surgery BOTOX to help close very large ventral hernias
This test tries a one-time image-guided BOTOX injection into the side abdominal muscles 3–7 weeks before open repair to see if it helps surgeons fully close very large ventral hernias in adults.
-
Patient-specific biomechanical modeling of incisional hernias with AI and finite element analysis
Researchers will test a personalized computer model of the abdominal wall for adults with incisional hernias using anonymized CT data and AI to see how the hernia shapes relate to tissue mechanics.
-
Risk factors for mesh infection after abdominal wall reconstruction
This study tests which factors put adults at risk for mesh infection after abdominal wall reconstruction using different mesh types.
-
Hernia Sac Flap Coverage of Mesh in Complex Bony-Edged Ventral Hernias
We’re testing whether using the patient’s own hernia sac as a living flap underneath the mesh helps healing after complex ventral hernia repair when part of the edge is bone.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.